Milestone Scientific receives NYSE American notice for non-compliance with listing standards

Published 14/10/2025, 12:58
Milestone Scientific receives NYSE American notice for non-compliance with listing standards

Milestone Scientific Inc. (NYSE American:MLSS) announced it received a letter from NYSE American stating the company is not in compliance with the continued listing standards under Sections 1003(a)(ii) and 1003(a)(iii) of the NYSE American Company Guide.

According to a press release statement included in a filing with the Securities and Exchange Commission, the notification was received on October 8. To maintain its listing, Milestone Scientific must submit a plan of compliance to the exchange by November 7, 2025. The plan should outline the actions the company has taken or intends to take to regain compliance with the listing standards.

If the plan is accepted by NYSE American, Milestone Scientific may continue its listing, but will be subject to periodic reviews by the exchange. If the plan is not accepted, or if the company does not make sufficient progress or fails to regain compliance by April 8, 2027, the exchange will begin delisting procedures as appropriate.

The company stated its management is evaluating options to address the deficiency and intends to submit a compliance plan before the deadline set by the exchange.

Milestone Scientific is incorporated in Delaware and is based in Livingston, New Jersey. The information is based on a press release statement included in the company’s SEC filing.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.